Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Cao, Yin, Huang, Sen, He, Yaohui, Zhang, Yuxiang, Chen, Simian, Huang, Mengxian, He, Fengming, Chen, Shutong, Wang, Di, Yang, Ziying, Zhao, Xinwei, Wang, Xiumin, Wu, Zhen, Ao, Mingtao, Qiu, Yingkun, Fang, Meijuan
Format: Artículo científico
Language:en
Published: Bioorganic chemistry 2025
Subjects:
Humans
Esophageal Squamous Cell Carcinoma
Cyclin-Dependent Kinases
Esophageal Neoplasms
Antineoplastic Agents
Protein Kinase Inhibitors
Structure-Activity Relationship
Cell Proliferation
Molecular Structure
Dose-Response Relationship, Drug
Animals
Drug Screening Assays, Antitumor
Drug Discovery
Mice
Pyrimidines
Mice, Nude
Cell Line, Tumor
Online Access:https://pubmed.ncbi.nlm.nih.gov/40056603/
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View
Description
Description not available.

Similar Items

  • Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
    by: Chen, Xiaohui, et al.
    Published: (2025)
  • Chemical Evolution of Aplithianine Class of Serine/Threonine Kinase Inhibitors.
    by: Du, Lin, et al.
    Published: (2025)
  • Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
    by: Mao, Churu, et al.
    Published: (2024)
  • Discovery of novel thiosemicarbazone dimers as effective inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1) for use in cancer therapy.
    by: Wang, Lijun, et al.
    Published: (2026)
  • Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
    by: Fang, Zhangyun, et al.
    Published: (2026)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs